Patient-derived iPSCs successfully model Dravet syndrome in vitro, demonstrating functional decline in GABAergic neurons.
No takes yet. Share an insight, caveat, or question.
Supports iPSC modeling of Dravet syndrome; leaves open clinical translation pending in vivo validation.
Higurashi et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: